Chatchai Muanprasat

Discovery of Glycine Hydrazide Pore-occluding CFTR Inhibitors

Chatchai Muanprasat, N.D. Sonawane, Danieli B. Salinas et al. · The Journal of General Physiology · 2004 · 258 citations · Full text

Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: Therapeutic efficacy and possible mechanisms of action

Mohammad S. Yousef, Rath Pichyangkura, Sunhapas Soodvilai et al. · Pharmacological Research · 2012 · 176 citations

Inflammation, Anti-inflammatory, Autoimmune Disease +11

Activation of AMPK by chitosan oligosaccharide in intestinal epithelial cells: Mechanism of action and potential applications in intestinal disorders

Chatchai Muanprasat, Preedajit Wongkrasant, Saravut Satitsri et al. · Biochemical Pharmacology · 2015 · 132 citations

Signal Transduction, Chitosan Oligosaccharide, Medicine +12

Chitosan oligosaccharide suppresses tumor progression in a mouse model of colitis-associated colorectal cancer through AMPK activation and suppression of NF-κB and mTOR signaling

Tharinee Mattaveewong, Preedajit Wongkrasant, Sumalee Chanchai et al. · Carbohydrate Polymers · 2016 · 102 citations

Inflammation, Tumor Biology, Gastrointestinal Oncology +10

Chitosan oligosaccharide suppresses synovial inflammation via AMPK activation: An in vitro and in vivo study

Wanlop Kunanusornchai, Bhee Witoonpanich, Tulyapruek Tawonsawatruk et al. · Pharmacological Research · 2016 · 68 citations

Inflammation, Anti-inflammatory, Autoimmune Disease +10